Jennerex appoints Dr James Burke VP of clinical research
This article was originally published in Scrip
Executive Summary
Jennerex, a San Francisco-based cancer biotherapeutics company, has appointed Dr James Burke to the newly-created position of vice-president of clinical research; he will be responsible for global clinical research activities related to Jennerex' pipeline. Dr Burke, who has 20 years' experience in the clinical science of genetic and immunotherapy, has been working with Jennerex in an advisory capacity as a clinical advisor for more than a year.